16:0 Cyclic LPA

<strong>16:0 Cyclic LPA</strong>_x000D_ <strong>Catalog number:</strong> B2019211_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 409.498_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> 16:0 Cyclic LPA,_x000D_ 1-hexadecanoyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt)_x000D_ cPAcLPA_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Liliom K, Murakami-Murofushi K, Kobayashi S, Murofushi H, Tigyi G. Xenopus oocytes express multiple receptors for LPA-like lipid mediators Am J Physiol. 1996 Mar;270(3 Pt 1):C772-7._x000D_ 2: Maeda-Sano K, Gotoh M, Morohoshi T, Someya T, Murofushi H, Murakami-Murofushi K. Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts Biochim Biophys Acta. 2014 Sep;1841(9):1256-63._x000D_ 3: Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, Özgüroğlu M; PACIFIC Investigators. Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer N Engl J Med. 2017 Nov 16;377(20):1919-1929._x000D_ 4: van der Spek A, Stewart ID, Kühnel B, Pietzner M, Alshehri T, Gauß F, Hysi PG, MahmoudianDehkordi S, Heinken A, Luik AI, Ladwig KH, Kastenmüller G, Menni C, Hertel J, Ikram MA, de Mutsert R, Suhre K, Gieger C, Strauch K, Völzke H, Meitinger T, Mangino M, Flaquer A, Waldenberger M, Peters A, Thiele I, Kaddurah-Daouk R, Dunlop BW, Rosendaal FR, Wareham NJ, Spector TD, Kunze S, Grabe HJ, Mook-Kanamori DO, Langenberg C, van Duijn CM, Amin N. Circulating metabolites modulated by diet are associated with depression Mol Psychiatry. 2023 Sep;28(9):3874-3887._x000D_ 5: Reeskamp LF, Tromp TR, Patel AP, Ibrahim S, Trinder M, Haidermota S, Hovingh GK, Stroes ESG, Natarajan P, Khera AV. Concordance of a High Lipoprotein(a) Concentration Among Relatives JAMA Cardiol. 2023 Dec 1;8(12):1111-1118._x000D_ 6: Ding X, Qin J, Huang F, Feng F, Luo L. The combination of machine learning and untargeted metabolomics identifies the lipid metabolism -related gene CH25H as a potential biomarker in asthma Inflamm Res. 2023 May;72(5):1099-1119._x000D_ 7: Leistner DM, Laguna-Fernandez A, Haghikia A, Abdelwahed YS, Schatz AS, Erbay A, Roehle R, Fonseca AF, Ferber P, Landmesser U. Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity Eur J Prev Cardiol. 2024 May 11;31(7):856-865._x000D_ 8: Trovato FM, Zia R, Artru F, Mujib S, Jerome E, Cavazza A, Coen M, Wilson I, Holmes E, Morgan P, Singanayagam A, Bernsmeier C, Napoli S, Bernal W, Wendon J, Miquel R, Menon K, Patel VC, Smith J, Atkinson SR, Triantafyllou E, McPhail MJW. Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure J Hepatol. 2023 Mar;78(3):558-573._x000D_ 9: Timm T, Hild C, Liebisch G, Rickert M, Lochnit G, Steinmeyer J. Functional Characterization of Lysophospholipids by Proteomic and Lipidomic Analysis of Fibroblast-like Synoviocytes Cells. 2023 Jun 29;12(13):1743._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/37958570">10: Requena-Ocaña N, Flores-López M, García-Marchena N, Pavón-Morón FJ, Pedraza C, Wallace A, Castilla-Ortega E, Rodríguez de Fonseca F, Serrano A, Araos P. Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder Int J Mol Sci. 2023 Oct 25;24(21):15586. </a>_x000D_ _x000D_ <strong>Products Related to 16:0 Cyclic LPA can be found at</strong> <a href="https://moleculardepot.com/product-category/Lipids/"> Lipids</a>